DataMeds AI Inc
datamedsai.comWhat Do They Do?
Distributes pharmaceutical products and provides logistics services to independent pharmacies and pharmaceutical manufacturers, while filling general and specialty prescriptions for patients.
10-K for FY2025, filed Mar 20, 2026
How Do They Make Money?
Pharmacies and manufacturers buy distributed products and logistics services; customers generally pay by card when ordering, while larger accounts pay after shipment. Prescription sales are paid by insurers, pharmacy benefit managers and patient copayments, with the sale completed when the prescription is delivered.
10-K for FY2025, filed Mar 20, 2026A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in…View ↗
Wellgistics, LLC provides distribution and third party logistics services to both pharmaceutical manufacturers and independent retail…View ↗
The current Wellgistics Pharmacy revenue model is based on prescription fulfillment and reimbursement from payors (i.e., insurance…View ↗
Step Five: Recognize revenue when or as the entity satisfies a performance obligation — Revenue is recognized upon the delivery of the…View ↗
-
10-K for FY2025, filed Mar 20, 2026
FY2025 revenue by product or service ↗
$23.3M
-
10-K for FY2025, filed Mar 20, 2026
$23.3M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2025, filed Mar 20, 2026 |
94% |
Product, FY2025
$21.9M Sources
|
Sold outright |
|
Pharmacy Retail Sales
Sold outright
|
3.7% |
Pharmacy Retail Sales, FY2025
$865.7K Sources
|
Sold outright |
|
Third Party Logistics Services
Sold outright
|
2.6% |
Third Party Logistics Services, FY2025
$603.4K Sources
|
Sold outright |
Who Are Their Customers?
Independent retail pharmacies buy from the wholesale operation, which also works with pharmaceutical manufacturers; the retail pharmacy fills prescriptions for patients and dispenses through 340B relationships with healthcare facilities.
10-K for FY2025, filed Mar 20, 2026
10-K for FY2025, filed Mar 20, 2026
Do Revenues Turn Into Profits?
No. It lost $101.3M in FY2025.
10-K for FY2025, filed Mar 20, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 17, 2026
−$18.4MView ↗
- ▲ +175% (Loss)
- vs −$6.7M in Q2 FY2025
-
Sep 11, 2026
Acquired Helomics, a cancer diagnostics and lab-services business
Helomics became a wholly owned subsidiary in a transaction involving company shares and a convertible note.
Sources
8-K, filed Sep 16, 2026
On September 11, 2026, DataMeds AI, Inc., a Delaware corporation (the “Company”), entered into a stock purchase agreement (the “Purchase…View ↗
-
Aug 4, 2026
Signed a letter of intent for technology assets and a Tollo Health stake
The proposed deal remains subject to definitive agreements, approvals, financing and other conditions.
Sources
8-K, filed Aug 4, 2026
As previously disclosed on May 20, 2026, DataMEDS AI, Inc. (formerly Wellgistics Health, Inc.) (the “Company”) entered into a Fully Binding…View ↗
Loading...
